Friday, November 1, 2024

10:00 AM - 10:25 AM

---

Details

Cell and gene therapies are revolutionising medicine, and they hold immense potential to transform health outcomes and the lives of Australia’s peoples. We are experiencing significant growth in this industry in part due to priority review pathways that fast-track therapeutics from bench to bedside and investment into genomic diagnostics. The therapeutic landscape remains strong globally with an increasing number of therapies approved for clinical use. Our keynote will outline why a holistic approach that considers clinical, operational and commercial capabilities, is needed to ensure promising technologies successfully progress through the pipeline.

---

Speaker